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Polychlorinated biphenyls (PCBs) are anthro-
pogenic industrial chemicals, the production
of which was banned in the 1970s because of
their presumed carcinogenicity (Chana et al.
2002). However, these chemicals are still pre-
sent in the food chain; they accumulate in ani-
mal and human tissues and are among the
most abundant persistent organic pollutants
found in humans (DeKoning and Karmaus
2000; Kim et al. 2004). Depending on their
degree of chlorination, they are metabolized to
their hydroxy- and/or sulfur-containing
metabolites (Haraguchi et al. 1997). PCBs can
cross the placenta, and infants are exposed via
contaminated breast milk (DeKoning and
Karmaus 2000).
Epidemiologic studies have indicated that
PCBs inﬂuence brain development (reviewed
by Schantz et al. 2003). Children who are
exposed during development exhibit neuro-
psychologic deﬁcits such as lower full-scale IQ
(intelligence quotient), reduced visual recog-
nition memory, and attention and motor
deficits (Ayotte et al. 2003; Darvill et al.
2000; Huisman et al. 1995a, 1995b; Osius
et al. 1999; Walkowiak et al. 2001). Results
from studies in rodents supported these ﬁnd-
ings (Berger et al. 2001; Lilienthal et al.
1990; Roegge et al. 2000; Widholm et al.
2001). PCBs decrease circulating levels of
thyroxine (T4) in animals (Brouwer et al.
1998; Gauger et al. 2004; Meerts et al. 2002).
The neuropsychologic findings in offspring
after developmental exposure to PCBs overlap
with those described for maternal thyroid insuf-
ﬁciency (Haddow et al. 1999; Morreale et al.
2000; Pop et al. 1999). However, exposure at
doses that lower serum thyroid hormone (TH)
did not always produce signs of hypo-
thyroidism [e.g., no elevation in TSH (Barter
and Klaassen 1992; Kolaja and Klaassen
1998), no lowering of body weight of rat pups
(Zoeller et al. 2000), and acceleration of eye
opening in rat pups that can also be caused by
high levels of TH (Goldey et al. 1995)].
Epidemiologic studies do not uniformly
find an association between PCBs and thy-
roid homeostasis. A negative correlation
between circulating levels of TH and PCB
exposure and a positive correlation between
the TH-regulating hormone thyrotropin
(TSH) and PCB exposure have been observed
(Osius et al. 1999; Schell et al. 2002). Others
found no association between PCB exposure
and disturbances of the TH pathway. This
may be due to comparing combined high-
and low-exposure groups to the reference
group. Nevertheless, all observed hormone
levels in these epidemiologic studies were
within the normal range (Hagmar 2003) [i.e.,
accidental exposure to PCBs was not associ-
ated with overt hypothyroidism (Nagayama
et al. 2001)]. 
Because there is no clear relationship
between PCB exposure, blood TH levels, and
symptoms of hypothyroidism in animals or in
humans, several investigators have speculated
that PCBs may affect brain development by
directly interfering with TH signaling
(McKinney and Waller 1998; Porterfield
2000; Porterfield and Hendry 1998).
Dowling and Zoeller (2000) showed that
RC3/neurogranin expression in the fetal rat
brain is controlled by TH of maternal origin.
This laboratory also demonstrated that the
technical PCB mixture Aroclor 1254 regu-
lated the TH-dependent genes myelin basic
protein and RC3/neurogranin in a TH-like
manner in animals (Zoeller et al. 2000).
Thus, despite the anti-thyroid effect of PCBs
on serum TH, they seem to act like TH at
the cellular level.
On the basis of these ﬁndings and because
no one has critically tested the hypothesis that
PCBs can inﬂuence developmental events in
the human brain, we asked two questions:
a) Do PCBs have a TH agonistic/antagonistic
effect on human neural development? and
b) Which mechanisms are involved? For these
purposes we established the model of normal
human neural progenitor (NHNP) cells
(Brannen and Sugaya 2000), which allow us to
study the effect of these environmental chemi-
cals on neural differentiation. Most studies on
the effects of PCBs use Aroclor, which consists
of many different PCB congeners. Rather than
deal with a heterogeneous group, we chose two
different speciﬁc PCB congeners: PCB-118, a
compound with weak dioxin-like activity, and
PCB-126, a congener with strong dioxin-like
properties (van den Berg et al. 1998). We
applied the single congener approach to iden-
tify specific PCB involvement in the distur-
bance of neural differentiation.
Materials and Methods
Chemicals. Triiodothyronine (T3; Sigma-
Aldrich, München, Germany) was diluted in
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Polychlorinated biphenyls (PCBs) are ubiquitous environmental chemicals that accumulate in
adipose tissues over the food chain. Epidemiologic studies have indicated that PCBs influence
brain development. Children who are exposed to PCBs during development suffer from neuro-
psychologic deﬁcits such as a lower full-scale IQ (intelligence quotient), reduced visual recognition
memory, and attention and motor deﬁcits. The mechanisms leading to these effects are not fully
understood. It has been speculated that PCBs may affect brain development by interfering with
thyroid hormone (TH) signaling. Because most of the data are from animal studies, we established
a model using primary normal human neural progenitor (NHNP) cells to determine if PCBs
interfere with TH-dependent neural differentiation. NHNP cells differentiate into neurons, astro-
cytes, and oligodendrocytes in culture, and they express a variety of drug metabolism enzymes and
nuclear receptors. Like triiodothyronine (T3), treatment with the mono-ortho-substituted
PCB-118 (2,3´,4,4´,5-pentachlorobiphenyl; 0.01–1 µM) leads to a dose-dependent increase of
oligodendrocyte formation. This effect was congener specific, because the coplanar PCB-126
(3,3´,4,4´,5-pentachlorobiphenyl) had no effect. Similar to the T3 response, the PCB-mediated
effect on oligodendrocyte formation was blocked by retinoic acid and the thyroid hormone receptor
antagonist NH-3. These results suggest that PCB-118 mimics T3 action via the TH pathway.
Key words: NH-3, NHNP cells, oligodendrocyte, PCB, retinoic acid, thyroid hormone receptors.
Environ Health Perspect 113:871–876 (2005). doi:10.1289/ehp.7793 available via http://dx.doi.org/
[Online 18 April 2005]
Researchethanol at a concentration of 300 mM.
Ortho-substituted PCB-118 (2,3´,4,4´,5-
pentachlorobiphenyl), coplanar PCB-126
(3,3´,4,4´,5-pentachlorobiphenyl (both from
Ökometric GmbH, Bayreuth, Germany), all-
trans-retinoic acid (RA; Sigma-Aldrich) and
the TH antagonist NH-3 (Nguyen et al. 2002)
were diluted in DMSO (Sigma-Aldrich) at
stock concentrations of 1.53, 1.59, 10, and
10 mM, respectively. Benzo(a)pyrene (BAP;
Sigma-Aldrich) was diluted in tetrahydrofuran
(10 mM).
Cell culture and treatment. NHNP cells
were purchased from Cambrex BioScience
(Verviers, Belgium) and cultured as neuro-
spheres in NPMM (Neural Progenitor
Maintenance Medium; Cambrex BioScience)
at 37°C with 5% CO2. Medium was changed
every 2–3 days. Upon significant growth
(0.7-mm diameter), spheres were chopped
with a McIlwaine tissue chopper as previously
described (Svendsen et al. 1998); the resultant
cubes formed new spheres within hours and
were named according to increasing passage
after each chopping event (passages 1–7).
For treatment of neurospheres, chemicals
were diluted in NPMM to the following ﬁnal
concentrations: 30 nM T3; 0.01 µM, 0.1 µM
and 1 µM PCB-118 and PCB-126; 10 µM
BAP; 1 µM each RA and NH-3; and 0.065%
DMSO. We treated 3–10 spheres with a
diameter of approximately 0.4 mm each for
7 days before plating for differentiation.
Spheres were treated with each chemical
alone or with a cotreatment containing
PCB-118 and either NH-3 or RA for 1 week.
Differentiation of NHNP cells was initiated
by growth factor withdrawal and plating
onto poly-D-lysine coated chamber slides
(BD Biosciences, Erembodegem, Belgium).
Neurospheres were plated in a deﬁned medium
consisting of Dulbecco modified Eagle
medium (DMEM)/F12 (3:1) supplemented
with N2 (Invitrogen GmbH, Karlsruhe,
Germany). After differentiating for 2 days, cells
were ﬁxed in 4% paraformaldehyde for 30 min
and stored in phosphate-buffered saline (PBS)
at 4°C until immunostaining was performed.
Immunocytochemistry. Fixed slides were
washed two times for 5 min each in PBS. Slides
were incubated with the following primary
antibodies: a) double staining beta(III)tubulin
1:100 and glial fibrillary acidic protein
(GFAP) 1:1,000 (both from Sigma-Aldrich)
in PBS containing 0.3% Triton X-100, or
b) mouse antioligodendrocyte marker O4 1:15
(Chemicon, Temecula, CA, USA) in PBS
with 10% goat serum for 1 hr at 37°C followed
by three 10-min washes with PBS. We used
fluorescein isothiocyanate (FITC)- and/or
Rhodamine Red-coupled secondary antibodies
(1:100 each; Jackson ImmunoResearch,
Dianova GmbH, Hamburg, Germany) for
detection by incubating slides for 30 min at
37°C, followed by three 10-min washes with
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Table 1. Sequences of oligonucleotides used to perform RT-PCRs with NHNP cells as shown in Figure 1.
Annealing
Gene Sequences Size (bp) temperature (°C) Reference
β-Actin  FW CCCCAGGCACCAGGGCGTGAT 263 60 Ihm et al. 2002
RW GGTCATCTTCTCGCGGTTGGCCTTGGGGT
NSE FW CCCACTGATCCTTCCCGATACAT 254 60 Kukekov et al. 1999
RW CCGATCTGGTTGACCTTGAGCA
GFAP FW GATCAACTCACCGCCAACAGC 206 60 Kukekov et al. 1999
RW CTCCTCCTCCAGCGACTCAATCT
PLP/dm20 FW CCATGCCTTCCAGTATGTCATC 354 PLP 59 Kukekov et al. 1999
RW GTGGTCCAGGTGTTGAAGTAAATGT 249 dm20
CYP1A1  FW TAGACACTGATCTGGCTGCAG 146 60 Omiecinski et al. 1990
RW GGGAAGGCTCCATCAGCATC
CYP1B1  FW AACGTCATGAGTGCCGTGTGT 360 63 Sutter et al. 1994
RW GGCCGGTACGTTCTCCAAATC
CYP2A6  FW CAGCTGAACACAGAGCAGATGTACA 227  60 Yengi et al. 2003
RW CGCTCCCCGTTGCTGAATA
CYP2B6  FW CATTCTTCCGGGGATATGGTG 83  60 Yengi et al. 2003
RW CCTCATAGTGGTCACAGAGAATCG
CYP2C9  FW GAGGAGTTTTCTGGAAGAGGCAT 130  60 Yengi et al. 2003
RW CAAAATTCCGCAGCGTCAT
CYP2C19  FW GAGGAGTTTTCTGGAAGAGGCC 76  60 Yengi et al. 2003
RW CATTGCTGAAAACGATTCCAAA
CYP2D6  FW CTTTCTGCGCGAGGTGCT 96  60 Yengi et al. 2003
RW TGGGTCAGGAAAGCCTTTTG
CYP3A4  FW TCTCATCCCAGACTTGGCCA 85  60 Yengi et al. 2003
RW CATGTGAATGGGTTCCATATAGATAGA
UGT1A6  FW TCCTGGCTGAGTATTTGGGCC 562  59 Strassburg et al. 1997
RW GTTCGCAAGATTCGATGGTCG
GSTM1  FW GAACTCCCTGAAAAGCTAAAGCT 132 60 Ko et al. 2000
RW GTTGGGCTCAAATATACGGTGG
GSTT1  FW TTCCTTACTGGTCCTCACATCTC 262 60 Ko et al. 2000
RW TCCCAGCTCACCGGATCAT
TRα1  FW CCCTGAAAACCAGCATGTCAG 150 68 Silva et al. 2002
RW TTCTTCTGGATTGTGCGGC
TRβ1  FW AAGTGCCCAGACCTTCCAAA 150 68 Silva et al. 2002
RW AAAGAAACCCTTGCAGCCTTC
TRβ2  FW GGGCTGGAGAATGCATGCGTAGACT 239 68 Gittoes et al. 1997
RW ATTCACTGCCCAGGCCTGTTCCATA
RAR-α FW ACCCCCTCTACCCCGCATCTACAAG 226 60 Kimura et al. 2002
RW CATGCCCACTTCAAAGCACTTCTGC
RAR-β FW ATTCCAGTGCTGACCATCGAGTCC 349 62 Kimura et al. 2002
RW CCTGTTTCTGTGTCATCCATTTCC
RAR-γ FW TACCACTATGGGGTCAGC 195 60 Kimura et al. 2002
RW CCGGTCATTTCGCACAGCT
RXR-α FW TTCGCTAAGCTCTTGCTC 113 58 Kimura et al. 2002
RW ATAAGGAAGGTGTCAATGGG
RXR-β FW GAAGCTCAGGCAAACACTAC 111 58 Kimura et al. 2002
RW TGCAGTCTTTGTTGTCCC
RXR-γ FW GCAGTTCAGAGGACATCAAGCC 352 62 Kimura et al. 2002
RW GCCTCACTCTCAGCTCGCTCTC
GenBank accession no.a/
position in sequence
AhR FW  TGGTCTCCCCCAGACAGTAG 132 60 BC070080/
RW TTCATTGCCAGAAAACCAGA 1113-1244
AhRR FW  CAGTTACCTCCGGGTGAAGA 161 60 NM_020731/
RW CCAGAGCAAAGCCATTAAGA 269-429
Abbreviations: AhR, arylhydrocarbon receptor; AhRR, AhR repressor; CYP, cytochrome P450; FW, forward primer; GST,
glutathione S-transferase; NSE, neuron specific enolase; PLP, proteolipid protein; RAR, retinoic acid receptor; RW,
reverse primer; RXR, retinoic x receptor; UGT, UDP glucuronosyltransferase; TR, thyroid hormone receptor.
aGenBank (2005).
Figure 1. Neurosphere plated on poly-D-lysine–
coated slides showing differentiation and radial
outgrowth of cells out of the sphere after 4 days in
culture. Phase contrast image. Bar = 200 µm.PBS. In the third wash, we added 0.1 µg/mL
Hoechst for nuclear staining. After brief dry-
ing, slides were mounted with Vectashield
Mounting Medium (Vector Laboratories,
Burlingame, CA, USA), covered with cover
glass, and sealed with nail polish.
Slides were examined using a fluorescent
microscope (Olympus, Hamburg, Germany),
and photographs were taken with a ColorView
XS digital camera (Olympus). We determined
the number of O4-positive oligodendrocytes
for each individual sphere by manual counting. 
Statistical analysis. The counts were
approximately lognormally distributed.
Therefore, we used the geometric mean and
the standard deviation of the geometric mean.
The t-test was performed after logarithmic
transformation of the values, and each treat-
ment was compared to its respective control.
The inhibition values were not logarithmically
transformed.
RNA preparation and reverse transcrip-
tion polymerase chain reaction. Total RNA
was prepared from 10–15 pooled untreated
and undifferentiated spheres (passages 0–2)
using the Absolutely RNA Microprep Kit
(Stratagene, La Jolla, CA, USA). Reverse tran-
scription polymerase chain reaction (RT-PCR)
was performed as previously described (Döhr
et al. 1995). Sequences and annealing
temperatures of the PCR primers are listed in
Table 1. Fragments were separated on a 3%
agarose gel containing ethidium bromide and
visualized under ultraviolet light. We used a
100-bp marker (peqlab, Erlangen, Germany)
to estimate the appropriate sizes of the PCR
fragments.
Results 
Cultivation and molecular characterization
of NHNP cells. Neurospheres were success-
fully kept in suspension culture over several
months. When they exceeded 0.7 mm in
diameter, they were passaged by chopping
into 0.3-mm cubes. This passaging was per-
formed up to seven times during the lifespan
of the NHNP cells. Plating of spheres onto
poly-D-lysine–coated chamber slides under
withdrawal of growth factors resulted in quick
radial outgrowth and differentiation of the
cells (Figure 1). After immunostaining, the
differentiated cells were identiﬁed as neurons,
astrocytes, and oligodendrocytes (Figure 2).
Furthermore, neurons seem to form a neu-
ronal network. 
To determine molecular characterization of
NHNP cells we performed RT-PCRs of cell
type–speciﬁc genes throughout the ﬁrst three
passages. We could identify typical gene prod-
ucts for the three different cell lineages in
undifferentiated neurospheres: neuron speciﬁc
enolase (NSE) for neurons, GFAP for astro-
cytes (Figure 3), and proteolipid protein with
its splicing variant dm20 (data not shown) for
oligodendrocytes. Finding these cell-specific
markers in undifferentiated cells implies that
speciﬁc cell fate is determined before plating
and differentiation of cells.
To ascertain if NHNP cells are suitable
for neurotoxicologic studies, we characterized
them for their expression of genes playing a
role in xenobiotic metabolism. The results
obtained from undifferentiated neurospheres
are shown in Figure 3. NHNP cells express
the aryl hydrocarbon receptor (AhR) and the
AhR repressor (AhRR), which represent cen-
tral proteins in the regulation of AhR battery
genes. Concerning phase 1 enzymes, we could
detect gene products for cytochrome P450
(CYP)1A1, CYP1B1, and CYP2D6, whereas
CYP2A6, CYP2B6, CYP2C9, CYP2C19, and
CYP3A4 were not expressed. With regard to
phase 2 enzymes, NHNP cells do express glu-
tathione S-transferase (GST)M1 and GSTT1,
but are abundant for UDP-glucuronosyl-
transferase (UGT)1A6. Hence, NHNP cells
have the ability to metabolize xenobiotics.
Our objective was to investigate endocrine
disruption of TH homeostasis in NHNP
cells; thus we studied the expression of genes
coding for thyroid hormone receptors (TR),
retinoid acid (RAR), and retinoid X receptors
(RXR), which are crucial molecules in hor-
mone signal transduction. Undifferentiated
NHNP cells express TRα1, β1, and β2, as
well as RARα and β and RXRα, β,and γ.
Therefore they represent a suitable cell model
for investigating thyroid hormone disruption.
Effects of T3 and PCBs on NHNP cells.
Our initial goal was to investigate the mecha-
nisms leading to disturbance of human brain
development in a human in vitro model.
Because disruption of thyroid hormone signal-
ing is suspected to be involved in impairment
of intellectual development by PCBs (reviewed
by Zoeller and Crofton 2000) and because the
timing of oligodendrocyte development seems
to be dependent on TH (reviewed by Konig
and Moura 2002), we investigated the occur-
rence of oligodendrocytes during differentiation
of NHNP cells. Therefore, undifferentiated
neurospheres were treated with 30 nM T3 for
1 week. After 2 additional days of differentia-
tion, we found a significant increase in the
PCBs disturb differentiation of NHNP cells
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Figure 2. Immunocytochemical staining of differentiated NHNP cells. (A) β(III)Tubulin-positive neurons
(green) and GFAP-positive astrocytes (red); nuclei stained with Hoechst. (B) O4-positive oligodendrocyte.
Figure 3. Expression patterns (RT-PCR) of different
drug-metabolizing enzymes (CYPs, GSTs, UGT), neural
markers (NSE, GFAP), and nuclear receptors (TRs,
RARs, RXRs) during passaging of undifferentiated
NHNP cells (P0–P2). RT-PCR was performed as previ-
ously described (Döhr et al. 1995). Respective primer
sequences are given in Table 1. [The unspecific
bands in some samples may be caused by the high
cycle numbers (40) needed for detection of speciﬁc
gene products due to the small amount of RNA
obtained from each sample.]number of oligodendrocytes formed compared
to the medium controls (Figure 4). Treating
neurospheres with PCB-118 for 1 week also
led to an increase in oligodendrocyte forma-
tion, whereas PCB-126 had no effect. It is
noteworthy that the solvent DMSO shows
some intrinsic effect in this system (Figure 4).
Thus, PCB-118 seems to have a TH-like effect
in NHNP cells.
Antagonism of T3 effects with RA and
NH-3. To determine whether the TH-like
effect of PCB-118 is mediated by TH recep-
tors, we cotreated NHNP cells with 30 nM
T3, 1 µM PCB-118, 1 µM RA, and 1 µM
NH-3, or in combination. After 1 week, we
counted the number of oligodendrocytes in the
neurospheres. Both RA and NH-3 treatment
prohibited the formation of oligodendrocytes
by T3 and PCB-118 while having no intrinsic
activity themselves (Figure 5). These results
support the conclusion that PCB-118 acts by
interfering with the TR complex.
Discussion
It is now generally accepted that developmental
exposure to drugs or chemicals can have adverse
effects on the structure or function of the ner-
vous system. Identiﬁcation of such substances
resulted mainly from epidemiologic data and
animal studies. It is important to develop
in vitro approaches because, in some cases,
severe species differences can exist (Harry et al.
1998; Tilson 1996). In this article, we charac-
terize an in vitro human neural model. To
demonstrate the toxicologic usefulness of this
model, we have shown the effects of two differ-
ent PCB congeners on neural development.
Although the ability of PCB congeners to
induce cytochrome P450 enzymes has been
intensively studied in rats (Parkinson et al.
1983), AhR-dependent toxic equivalency fac-
tors were revised at an expert meeting orga-
nized by the World Health Organization (van
den Berg et al. 1998). In this report, van den
Berg et al. (1998) described PCB-118 as a
compound with weak dioxin-like activity and
PCB-126 as a congener with strong dioxin-like
properties. The present ﬁndings demonstrate
that an individual PCB congener known to
widely contaminate human populations can
alter the course of neural differentiation in pri-
mary NHNP cells. This effect was restricted to
PCB-118, which has weak dioxin-like activity,
and was not observed following treatment with
PCB-126, a dioxin-like congener, despite the
fact that these cells express the dioxin receptor
(AhR). Moreover, the effect of PCB exposure
on oligodendrocyte differentiation was similar
to the effect of T3 and could be blocked by the
T3 antagonist NH-3. Therefore, these ﬁndings
suggest that nondioxin-like PCB congeners
such as PCB-118 may directly interfere with
TH signaling in the developing human brain,
altering the course of neural differentiation and
potentially accounting for the observation that
exposure to PCBs is linked to cognitive deﬁcits
in the human population.
We are the ﬁrst to establish a human pri-
mary cell model for investigating endocrine
disruption in neural development. NHNP
cells, which have the ability to differentiate
into the three major cell types of the human
brain—neurons, astrocytes, and oligodendro-
cytes (Figure 2)—formed the basis of this
model. The number of oligodendrocytes was
relatively low, with approximately 30% of the
differentiated cells being neurons and approxi-
mately 70% appearing as astrocytes (data not
shown). Other laboratories have reported a dis-
tinct distribution pattern of neurons and glia
cells in human neurospheres (Buc-Caron
1995; Caldwell et al. 2001; Kanemura et al.
2002; Messina et al. 2003; Piper et al. 2001).
These differences may be due to culture condi-
tions, ages of the embryos/fetuses, or the brain
areas from which the cells were prepared.
Nevertheless, the low abundance of oligoden-
drocytes in NPHH cells provides a very sensi-
tive system to identify agents that induce their
differentiation.
Two important features of our in vitro
model support their use in studies of chemical
exposure on neurodevelopment: their xeno-
biotic metabolic capacity and their TH signal
transduction machinery. mRNA analyses
reveal that NHNP cells express a variety of
phase 1 and phase 2 enzymes (Figure 3),
which indicates that the cell may be capable
of xenobiotic metabolism. This is important
because the parent PCB congeners may be
metabolized before developing toxicity (James
2001). In regard to the expression pattern of
phase 1 and phase 2 enzymes, no data are
available for the developing human brain.
However, in adult brain, the expression of
CYPs differs partially from NHNP cells
(Nishimura et al. 2003); we did not identify
CYP2A6 or CYP3A4 expression in NHNP
cells, but adult brain exhibits a relatively high
abundance of these enzymes compared with
CYP1A1 expression. In contrast, neurospheres
expressed CYP1A1, CYP1B1, and CYP2D6.
These enzymes are also present in adult brain
(Nishimura et al. 2003). Furthermore, NHNP
cells express phase 2 enzymes; GSTM1 and
GSTT1 were present in NHNP cells and were
found in human brain tissue as well (Sherratt
et al. 1997). To the contrary, human adult
brain, but not NHNP cells, expressed
UGT1A6 (King et al. 1999). Because of the
abundance of phase 1 and phase 2 enzymes,
we consider NHNP cells to be a suitable
Fritsche et al.
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Figure 4. Induction of O4-positive (+) oligodendrocytes per sphere (geometric mean and SD) by T3 or
PCB-118. Photographs show typical results of treatments (bars = 100 µm). Neurospheres were treated with
T3 or PCBs as described in “Materials and Methods.” Values represent typical representatives of three
independent experiments.
*p < 0.05, and **p < 0.01 by t-test.
Figure 5. Antagonism of T3- or PCB-118-induced oligodendrocyte formation by (A) NH-3 and (B) RA. See
“Materials and Methods” for details. Inhibitions are shown as a percentage of T3 or PCB-118 controls,
respectively. Values represent typical representatives of three independent experiments.
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)toxicologic model for studying the effects of
xenobiotics on the human developing nervous
system. 
TH and RA are fundamental for brain
development (reviewed by Bernal et al. 2003
and by McCaffery et al. 2003). They exert their
actions through nuclear hormone receptors
(i.e., TR, RAR, and RXR). An important
premise for investigating endocrine disruption
of the thyroid hormone system by PCB is
expression of the involved receptors; TRα1,
β1, and β2, as well as all RAR and RXR iso-
forms, with exception of RARg, were present
in NHNP cells. This is in agreement with the
distribution of these receptors in adult rodent
brains (Zetterstrom et al. 1999). TR mRNA
and protein was also detected in human fetal
brain (Bernal and Pekonen 1984; Kilby et al.
2000). 
In the present study, we found that the
mono-ortho-substituted PCB-118, as well as
TH, leads to an increased formation of oligo-
dendrocytes in NHNP cells. The develop-
ment of oligodendrocytes, which are the
myelin producing cells in the central nervous
system, is dependent on TH, which aids pro-
liferation and survival of oligodendrocyte pre-
progenitor cells (Barres et al. 1994; Ben Hur
et al. 1998; Schoonover et al. 2004). The
importance of TH for oligodendrocyte for-
mation was further conﬁrmed in hypothyroid
animals exhibiting fewer numbers of oligo-
dendrocytes than control animals (Ahlgren
et al. 1997). 
PCBs have been observed to have an
intrinsic TH-like effect: rat pups exposed to
Aroclor 1254 opened their eyes at an earlier
time point, an effect that is elicited with an
excess of T4 (Brosvic et al. 2002; Goldey et al.
1995). In addition, in pregnant animals
Aroclor treatment led to an increased expres-
sion of TH-dependent genes such as RC3/
neurogranin and myelin basic protein in fetal
brains (Zoeller et al. 2000), although PCB can
cause a decrease of serum TH levels (Gauger
et al. 2004; Meerts et al. 2002; Morse et al.
1993, 1996). Most studies performed on the
effects of PCBs used Aroclor, technical mix-
tures of PCBs containing planar and nonpla-
nar congeners. Because of the heterogeneity of
these mixtures, we decided to apply a single
congener approach with two different pen-
tachlorbiphenyls that have weak and strong
dioxin-like activities, respectively. Our results
show for the ﬁrst time that PCB-118 exerts a
TH-like effect on a cellular level in primary
human cells by increasing the number of
oligodendrocytes (Figure 4). 
In our study of the molecular mechanism
of PCB effects on oligodendrocytes, we inves-
tigated the TH-like effect of PCB-118 and
whether it is mediated through the TH recep-
tor complex. Therefore, we performed the
experiments in the presence of the speciﬁc TR
antagonist NH-3. NH-3 binds to the ligand-
binding domain of the TRs, with selectivity
for TRβ over TRα, leading to a conforma-
tional change of the receptor with release of
TR corepressors. Unlike TH, NH-3 prohibits
the subsequent recruitment of TR coactiva-
tors. Speciﬁcity of TRβ inhibition was shown
in vitro and in vivo (Lim et al. 2002; Nguyen
et al. 2002). In the presence of NH-3 the
formation of oligodendrocytes by TH and
PCB-118 was blocked (Figure 5A), which
may indicate that the TRβ complex is
involved in PCB-118–mediated effects on
oligodendrocyte differentiation. Because
Gauger et al. (2004) showed that a large vari-
ety of PCBs, including PCB-118, and their
metabolites do not competitively bind to TR,
we speculate that the TH-like effect of
PCB-118 on neural differentiation is due to
facilitation of coactivator binding. 
In another approach to investigate
whether PCB-118 acts through the TR com-
plex, we cotreated NHNP cells with RA. As
shown in Figure 5B, RA anticipated oligo-
dendrocyte formation induced by TH or
PCB-118 treatment. RA binds to the RAR
receptor, which shares its heterodimerization
partner RXR with several other nuclear recep-
tors including TR (reviewed by Rowe 1997).
Therefore, we suggest that antagonism of TH
or PCB-118 by RA is caused by competition
over RXR. A similar antagonism of TH by
RA has been described by Davis and Lazar
(1992), and it has been hypothesized that par-
ticipation of RXR in other activation path-
ways may modify the cellular response to TH
(Sarlieve et al. 2004).
Regarding the metabolic capacity of these
progenitor cells, we cannot exclude that the
observed induction of oligodendrocytes by
PCB-118 is a result of PCB metabolites rather
than the parent substance, and further experi-
ments are needed. However, the observed
effect is congener specific because PCB-126
did not increase oligodendrocytes in NHNP
cells. PCB-126 is a coplanar biphenyl that
activates the AhR, whereas PCB-118 is mono-
ortho substituted and exerts only weak AhR
agonist activity (Hestermann et al. 2000). The
inability of BAP, a classical AhR agonist, to
induce oligodendrocyte formation in NHNP
cells (data not shown) supports the suggestion
that the AhR is not involved in the distur-
bance of neural differentiation.
In summary, we developed a primary
human in vitro model for investigating
endocrine disruption of neural development.
We identified the mono-ortho-substituted
PCB-118 as a TH disrupter on human neural
development because it induced oligo-
dendrocyte formation in NHNP cells. In
contrast, PCB-126, a coplanar AhR ligand,
showed no hormone-like activity. The effects
seen after PCB-118 treatment seem to be
mediated through the TR complex because
they can be antagonized by the TR antagonist
NH-3 and by RA. The precise molecular
mechanisms require further elucidation.
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